Alzheimers & Dementia

简称Alzheimers Dement
大类医学
小类临床神经病学
ISSN1552-5260
EISSN1552-5279

最新文献

Life's Essential 8, genetic susceptibility, and risk of cognitive impairment: results from an elder population-based cohort study

PMID: 421517092026-05

Neurovascular-metabolic dysregulation, metabolic connectomics, and metabolic functional changes in Alzheimer's disease: A preclinical and clinical comparison

PMID: 421517242026-05

Metabotropic glutamate receptor 5 is associated with plasma GFAP dependent on age

PMID: 421517232026-05

Altered amygdala structural connectivity and relations to social cognition in frontotemporal dementia

PMID: 421516262026-05

Elevated AD biomarkers do not explain cognitive performance in a community-recruited clinical trial cohort

PMID: 421517352026-05

Speech-based digital cognitive assessment for clinical trials: Detecting cognitive impairment stages and AD biomarker relations across European cohorts

PMID: 421516612026-05

Cognitive dispersion profiles and prediction of cognitive change in early-onset dementias: Results from LEADS

PMID: 421517322026-05

Physical activity, aerobic fitness, and AD blood biomarkers: The IGNITE study

PMID: 421511042026-05

Changes in arterial stiffness under blood pressure control are independently associated with cognitive impairment: The Systolic Blood Pressure Intervention Trial (SPRINT)

PMID: 421517442026-05

Associations of the Lifestyle for Brain Health (LIBRA) index with cognitive functioning across adulthood: Variation by sex and socioeconomic status in the German National Cohort (NAKO)

PMID: 421517372026-05

Remote, unsupervised assessment of cognitive impairment and decline in Alzheimer's disease using the Cogstate Brief Battery in ADNI-3

PMID: 421381822026-05

Minor neuropsychological deficits and stage 2 of Alzheimer's disease

PMID: 421295772026-05

A sensorimotor function construct to assess mild cognitive impairment risk

PMID: 421321372026-05

Mandarin speech-based early detection of SCD: a feature-fusion residual network method

PMID: 421294622026-05

Value-based prices of emerging disease-modifying therapies for Alzheimer's disease in 174 countries: a cost-effectiveness and threshold analysis

PMID: 421259952026-05

Technology access and preferences for remote assessments at Alzheimer's Disease Research Centers

PMID: 421158242026-05

Selective reduction of KCNA4 in vulnerable glutamatergic-serotonin neurons of the dorsal raphe nucleus in Alzheimer's disease

PMID: 421174852026-05

Advancing biomarker development for chronic traumatic encephalopathy: Summary and recommendations from the 2025 Leon Thal Summit

PMID: 421212012026-05

Practices and experiences of nursing staff delivering acute care for people with dementia in surgical-medical wards in Chile: qualitative study

PMID: 421212972026-05

Metabolomic ageing (MileAge) in mid-life predicts incident vascular, unspecified and all-cause dementia

PMID: 421260022026-05